Vittia Annual Report 2022
VITTIA
Our intention, in the short, medium, and long
term, is to continue growing in a responsible,
balanced, conscious and sustainable way,
either through organic growth - development
of new products and/or expansion of activities
and facilities -, or through acquisitions,
partnerships and other opportunities.
In the short term, with the planting of the last
crop started at a strong pace and appropriate
prices of the main agricultural commodities in
the international markets, we understand that
there are good productivity prospects for the
farmer. With favorable weather conditions and
agricultural prices in international markets
maintained at an adequate level, we have a
perspective of closing the summer harvest
with good profitability for rural producers.
We believe in a year with a favorable scenario
for the 2022/2023 harvest and we will continue
with our investment plan, with a priority focus
on the biological products segment. In February
2023, we acquired Agro21 Soluções Aéreas e
Agronômicas, a company specialized in the
aerial application of macrobiologicals, via
drones. With the acquisition, we reinforced
our position in the segment, starting to offer, in
addition to the biological input, the application
service to the farmer, closing the management
cycle with the customer.
Another important piece of news, especially
for investors, is the release of trading in the
Company's shares to retail investors, after an
18-month grace period related to the IPO held
in September 2021. In addition, in 2023, we
will also hold the 2nd edition of the Investor
Day by Vittia, an event that achieved great
repercussions in 2022.
With the current customer base, we intend to
explore sales and cross or complementary
business opportunities more intensely, with
the support, in particular, of our Vit Integra
program, which offers our customers complete
guidance on the integrated management of
products and on different solutions.
We will continue to direct great efforts
towards development, research, and
innovation. We have several fronts in this
direction, among which biological products
have stood out, which have significant potential
for the coming years.
Annual Report 2022
123View entire presentation